Embodiment of the present invention is related to treatment, inhibition or the method for mitigating microorganism infection in microorganism infection or the individual for having the risk that this infection occurs comprising the step of applying a effective amount of TLR9 and TLR2/6 agonist to the individual.本發明的實施方案涉及在患有微生物感染或有發生這種感染之風險的個體中治療、抑制或减輕微生物感染的方法,其包括向所述個體施用有效量的TLR9和TLR2/6激動劑的步驟。